Sab Biotherapeutics, Inc. · NASDAQ:SABS
Sab Biotherapeutics, Inc. shareholders
As of Jun 30, 2026, 84 institutions reported holding Sab Biotherapeutics, Inc., 75.2% of its shares. Largest: Caligan Partners LP, Vivo Capital, LLC and Perceptive Advisors LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Sab Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Caligan Partners LP | 7.97M | 8.8% | no change | Aug 14, 2026 |
| Vivo Capital, LLC | 7.3M | 8.0% | −4.12M | Aug 14, 2026 |
| Perceptive Advisors LLC | 6.63M | 7.3% | +196K | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 6.41M | 7.0% | +3M | Aug 14, 2026 |
| Ra Capital Management, L.P. | 4.4M | 4.8% | no change | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 3.76M | 4.1% | no change | Aug 14, 2026 |
| Vanguard | 3.65M | 4.0% | +948K | Aug 13, 2026 |
| BlackRock | 3.07M | 3.4% | +2.76M | Aug 7, 2026 |
| Commodore Capital LP | 2.87M | 3.2% | −1.53M | Aug 14, 2026 |
| Millennium | 2.75M | 3.0% | −284K | Aug 14, 2026 |